With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
NEW YORK (Reuters Health) – A low-dose oral contraceptive is effective in relieving primary dysmenorrhea, according to the results of a randomized controlled trial conducted in Japan and…
NEW YORK (Reuters Health) – Patients with advanced cervical carcinoma have better progression-free survival when gemcitabine is added to concurrent cisplatin chemoradiotherapy and included in adjuvant therapy, an…
NEW YORK (Reuters Health) – Including the postcoital test in the basic fertility workup does not add substantially to an existing prediction model for spontaneous pregnancy in subfertile…
NEW YORK (Reuters Health) – Performing fetal blood sampling (FBS) in women in early labor (cervical dilation to 3 centimeters or less) or performing multiple FBS procedures may…
NEW YORK (Reuters Health) – In the short term, uterine artery embolization (UAE) for symptomatic uterine fibroids has advantages over hysterectomy or myomectomy in terms of faster recovery,…
NEW YORK – Women with heavy or prolonged periods benefit from treatment with an oral contraceptive formulation that combines step-down estradiol valerate with step-up dienogest, a report in…
NEW YORK (Reuters Health) – Screening pregnant women for chlamydia using urine samples is just as accurate as when cervical secretions are used, suggests a new study published…
NEW YORK (Reuters Health) – For abortion in the second trimester performed for fetal anomalies or fetal death, dilation and evacuation (D&E) is considerably safer than the labor-induction…
NEW YORK (Reuters Health) – In cases of benign disease, hysterectomy performed laparoscopically is associated with less postop pain and faster recovery compared with vaginal hysterectomy, according to…
NEW YORK (Reuters Health) — Transcervical Foley catheter is just as effective for inducing vaginal labor as intravaginal misoprostol, but carries less risk of tachysystole, according to a…
